Community Academic Profiles

Robert Harrington

Publication Details

  • Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease.

    Petersen JL, Yow E, AlJaroudi W, Shaw LK, Goyal A, McGuire DK, Peterson ED, Harrington RA. Circ Cardiovasc Qual Outcomes. 2010; 3 (2): 165-72

    Metabolic syndrome (MetSyn) is associated with increased cardiovascular risk in the general population. Its prognostic implications are less well defined in patients with coronary artery disease.

    PubMedID: 20179266

Stanford Medicine Resources:

Footer Links: